Abstract:OBJECTIVE:To analyze the differences of clinical manifestations and laboratory features between primary Sjögren's syndrome (pSS) patients with positive and negative anti-Sjögren's syndrome type B (SSB) antibody.METHODS:The clinical data of pSS patients hospitalized in Department of Rheumato-logy and Immunology, Peking University Third Hospital were retrospectively analyzed to investigate the differences of clinical and laboratory features between anti-SSB positive and negative groups. The t test, Mann-Whitney U test, Chi-square test and Fisher's exact probability were used for analysis.RESULTS:A total of 142 pSS patients were enrolled in this study, including 137 females and 5 males with a mean age of (54.8±13.3) years. The anti-SSB positive group included 44 patients accounting for 31.0% of the pSS patients. The anti-SSB positive pSS patients were younger at disease onset and at visit [age at visit: (50.9±14.5) years vs. (56.5±12.4) years; age at onset: (42.2±14.8) years vs. (49.5±15.3) years, P < 0.05]. The patients with anti-SSB positive more frequently presented with rash (29.5% vs. 14.3%, P < 0.05), enlargement of parotid glands (27.3% vs. 8.2%, P < 0.05), renal tubular acidosis (15.9% vs. 4.2%, P < 0.05), immune thrombocytopenia (9.1% vs. 1.0%, P < 0.05), rheumatoid factor (RF) positive (85.0% vs. 49.4%, P < 0.05), higher RF and antinuclear antibody (ANA) titers (median: 89.8 IU/mL vs. 20.5 IU/mL; median: 320 vs. 160, P < 0.05), anti-Sjögren's syndrome type A (SSA) antibody positive (97.7% vs. 64.3%, P < 0.05), elevation of γ globulin (71.4% vs. 38.5%, P < 0.05), higher levels of IgG (median: 21.0 g/L vs. 15.6 g/L, P < 0.05), higher proportions of CD3-CD19+ cells [(21.0±11.9)% vs. (13.7±9.6)%, P < 0.05] and lower proportions of CD3+ cells [(67.2±14.4)% vs. (76.6%±13.1)%, P < 0.05] than those negative. However, the anti-SSB positive group was less likely to show anti-mitochondrial antibodies (AMA)-M2 positivity (10.5% vs. 35.6%, P < 0.05). Glucocorticoids (90.9% vs. 73.5%, P < 0.05) and immunosuppressants (54.5% vs. 36.7%, P < 0.05) were more frequently used in anti-SSB positive pSS patients than those negative.CONCLUSION:The anti-SSB positive pSS patients were younger at disease onset while more frequently presenting with various symptoms, higher levels of other antibodies and activation of B cells than those negative. Glucocorticoids and immunosuppressants were more frequently used, indicating that anti-SSB positive group presented with a more severe clinal phenotype.

Gender Differences in Clinical and Immunological Characteristics and the Pathogenic Study of Primary Sj(o)gren's Syndrome

Advances in the Pathogenesis and Treatment of Primary Sj(o)gren's Syndrome

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjogren's syndrome

Gender difference of primary Sjögren’s Syndrome in a Chinese cohort: Why do women suffer more?

The clinical characteristics of 573 cases of primary Sj(o)gren's syndrome

[Comparison of Clinical and Immunological Characteristics Between Primary Sjögren's Syndrome Patients with Positive and Negative Anti-Ssb Antibody].

Clinical stratification of 1318 Primary Sjögren's Syndrome patients

Clinical characteristics of primary Sj?gren′s syndrome-associated interstitial lung disease

Serum biomarker-based risk model construction for primary Sjögren's syndrome with interstitial lung disease

The Correlation between Serological Profiles and Clinical Features of Parotid Glands in Primary Sj?gren’s Syndrome

[Analysis of the Clinical Features at Onset of Primary Sjögren's Syndrome].

Expression of FcγRⅡb on peripheral B cells and its clinical significance in patients with primary Sj(o)gren's syndrome

[Serum IL-21 Level in Patients with Primary Sjogren's Syndrome and Clinical Significance of IL-21].

Clinical features of newly-diagnosed primary Sj(o)gren's syndrome: analysis of 86 cases

Male patients with primary Sjögren's syndrome have unique clinical manifestations and circulating lymphocyte profiles

Immunophenotypes and clinical features of lymph ocytes in labial gland of patients with primary Sj(o)gren's syndrome

Clinical analysis of the neurological involvement in primary Sj(o)gren's syndrome

Clinical features of interstitial lung disease in primary Sj(o)gren's syndrome

Impact of sex differences on the clinical presentation, pathogenesis, treatment and prognosis of Sjögren's syndrome

Clinical characteristics of Sj(o)gren's syndrome accompanied with interstitial lung disease